TipRanks
CytoDyn (DE:296)
STUTTGART:296

Compare CytoDyn (296) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
CytoDyn
€0.17
€261.03M
-5.83
-24.11%
―
Agenus
$8.36
$377.55M
3.08
112.18%
4 Buy
0 Hold
0 Sell
Strong Buy
Coherus Biosciences
$1.37
$179.22M
-1.14
-30.12%
4 Buy
0 Hold
0 Sell
Strong Buy
MacroGenics
$4.04
$228.05M
-16.27
109.36%
2 Buy
2 Hold
0 Sell
Moderate Buy
ADC Therapeutics
$1.05
$144.26M
-1.71
-71.61%
1 Buy
1 Hold
0 Sell
Moderate Buy
OmniAb
$4.47
$708.05M
-13.53
202.48%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:296
CytoDyn
0.17
-0.05
-24.11%
AGEN
Agenus
8.36
4.21
101.45%
CHRS
Coherus Biosciences
1.16
-0.54
-31.76%
MGNX
MacroGenics
3.58
1.82
103.41%
ADCT
ADC Therapeutics
1.13
-3.30
-74.49%
OABI
OmniAb
4.87
3.19
189.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts